Abstract
The hepatitis B vaccine used in NSW is of the recombinant or genetically engineered type. The genetic material within the DNA of the hepatitis B virus was initially cloned into the DNA of Escherichia coli, enabling the isolation of the S-gene and its incorporation into an expression plasmid containing the components necessary for replication and maintenance in yeast cells.
